Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease

References

• Iuliano L. Pathways of cholesterol oxidation via non- enzymatic mechanisms. Chem Phys Lipids 2011;164: 457–468.
   PubMed Web of Science ®Google Scholar
• Vejux A, Malvitte L, Lizard G. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res 2008;41:545–556.
   PubMed Web of Science ®Google Scholar
• Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998;39: 1529–1542.
   PubMed Web of Science ®Google Scholar
• Gill S, Chow R, Brown AJ. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog Lipid Res 2008;47:391–404.
   PubMed Web of Science ®Google Scholar
• Smith LL. In: Smith LL (ed.). Cholesterol autoxidation. New York: Plenum Press; 1981;125–199.
   Google Scholar
• Smith LL, Johnson BH. Biological activities of oxysterols. Free Radic Biol Med 1989;7:285–332.
   PubMed Web of Science ®Google Scholar
• Smith LL. Review of progress in sterol oxidations: 1987-1995. Lipids 1996;31:453–487.
   PubMed Web of Science ®Google Scholar
• Segala G, de Medina P, Iuliano L, Zerbinati C, Paillasse MR, Noguer E, et al. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cells. Biochem Pharmacol 2013;86:175–189.
   Google Scholar
• Bjorkhem I, Eggertsen G. Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol 2001;12:97–103.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Reihner E, Angelin B, Ewerth S, Akerlund JE, Einarsson K. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res 1987;28:889–894.
   PubMed Web of Science ®Google Scholar
• Heverin M, Meaney S, Brafman A, Shafir M, Olin M, Shafaati M, et al. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler Thromb Vasc Biol 2007;27:2191–2197.
   PubMed Web of Science ®Google Scholar
• Bodin K, Bretillon L, Aden Y, Bertilsson L, Broome U, Einarsson C, Diczfalusy U. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 2001;276:38685–38689.
   PubMed Web of Science ®Google Scholar
• Diczfalusy U, Miura J, Roh HK, Mirghani RA, Sayi J, Larsson H, et al. 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. Pharmacogenet Genomics 2008;18:201–208.
   PubMed Web of Science ®Google Scholar
• Russell DW. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 2000;1529:126–135.
   PubMed Web of Science ®Google Scholar
• Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA. Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J Biol Chem 2011;286:5607–5613.
   PubMed Web of Science ®Google Scholar
• Brown AJ, Jessup W. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol Aspects Med 2009;30:111–122.
   PubMed Web of Science ®Google Scholar
• Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 1999;96:7238–7243.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998;39:1594–1600.
   PubMed Web of Science ®Google Scholar
• Bretillon L, Diczfalusy U, Bjorkhem I, Maire MA, Martine L, Joffre C, et al. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr Eye Res 2007;32:361–366.
   PubMed Web of Science ®Google Scholar
• Lund EG, Kerr TA, Sakai J, Li WP, Russell DW. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem 1998;273:34316–34327.
   PubMed Web of Science ®Google Scholar
• Cardenia V, Rodriguez-Estrada MT, Boselli E, Lercker G. Cholesterol photosensitized oxidation in food and biological systems. Biochimie 2013;95:473–481.
   PubMed Web of Science ®Google Scholar
• Lange Y, Ye J, Strebel F. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J Lipid Res 1995;36: 1092–1097.
   PubMed Web of Science ®Google Scholar
• Russell DW. Nuclear orphan receptors control cholesterol catabolism. Cell 1999;97:539–542.
   PubMed Web of Science ®Google Scholar
• Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000;16:459–481.
   PubMed Web of Science ®Google Scholar
• Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001;262: 257–265.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I. Do oxysterols control cholesterol homeostasis?J Clin Invest 2002;110:725–730.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Andersson U, Ellis E, Alvelius G, Ellegard L, Diczfalusy U, et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem 2001;276:37004–37010.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res 2013;52:175–191.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 2008;8:512–521.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan A, Sun LP, Kwon HJ, Brown MS, Goldstein JL. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Cell 2004;15:259–268.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A 2007;104: 6511–6518.
   PubMed Web of Science ®Google Scholar
• DeBose-Boyd RA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 2008;18:609–621.
   PubMed Web of Science ®Google Scholar
• Kandutsch AA, Chen HW, Heiniger HJ. Biological activity of some oxygenated sterols. Science 1978;201:498–501.
   PubMed Web of Science ®Google Scholar
• Kandutsch AA, Thompson EB. Cytosolic proteins that bind oxygenated sterols. Cellular distribution, specificity, and some properties. J Biol Chem 1980;255:10813–10821.
   PubMedGoogle Scholar
• Xu Y, Liu Y, Ridgway ND, McMaster CR. Novel members of the human oxysterol-binding protein familybind phospholipids and regulate vescicles transport. J Biol Chem 2001;276:18407–18414.
   PubMed Web of Science ®Google Scholar
• Saucier SE, Kandutsch AA, Gayen AK, Swahn DK, Spencer TA. Oxysterol regulators of 3-hydroxy-3-methylglutaryl-CoA reductase in liver. Effect of dietary cholesterol. J Biol Chem 1989;264:6863–6869.
   PubMed Web of Science ®Google Scholar
• Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728–731.
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137–3140.
   PubMed Web of Science ®Google Scholar
• Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 2001;276:38378–38387.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003;17:985–993.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003;9:213–219.
   PubMed Web of Science ®Google Scholar
• Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30:1513–1518.
   PubMed Web of Science ®Google Scholar
• Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 2002;99:7604–7609.
   PubMed Web of Science ®Google Scholar
• Schuster GU, Parini P, Wang L, Alberti S, Steffensen KR, Hansson GK, et al. Accumulation of foam cells in liver X receptor-deficient mice. Circulation 2002;106: 1147–1153.
   PubMed Web of Science ®Google Scholar
• Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000;14:2831–2838.
   PubMed Web of Science ®Google Scholar
• Lo Sasso G, Murzilli S, Salvatore L, D’Errico I, Petruzzelli M, Conca P, et al. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 2010;12:187–193.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Grillot D, Billheimer JT, Briand F, Delerive P, Huet S, Rader DJ. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2010;30:781–786.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers?Arterioscler Thromb Vasc Biol 2002; 22:734–742.
   PubMed Web of Science ®Google Scholar
• Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab 2007;5: 73–79.
   PubMed Web of Science ®Google Scholar
• Shafaati M, Olin M, Bavner A, Pettersson H, Rozell B, Meaney S, et al. Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo. J Intern Med 2011;270:377–387.
   Google Scholar
• Olkkonem VM, Beaslas O, Nissila E. Oxysterols and their cellular effectors. Biomolecules 2012;2:76–103.
   Google Scholar
• Garenc C, Julien P, Levy E. Oxysterols in biological systems: the gastrointestinal tract, liver, vascular wall and central nervous system. Free Radic Res 2010;44:47–73.
   PubMed Web of Science ®Google Scholar
• Iuliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin E supplementation. Circulation 2000;101:1249–1254.
   Google Scholar
• Micheletta F, Natoli S, Misuraca M, Sbarigia E, Diczfalusy U, Iuliano L. Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol 2004;24:136–140.
   PubMed Web of Science ®Google Scholar
• Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1–28.
   PubMed Web of Science ®Google Scholar
• Guardiola F, Dutta PC, Codony R, Savage GP. Cholesterol and phytosterol oxydation products: analysis, occurrence, and biological effects. Champaign: AOCS; 2002.
   Google Scholar
• Colles SM, Maxson JM, Carlson SG, Chisolm GM. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc Med 2001;11:131–138.
   PubMed Web of Science ®Google Scholar
• Prunet C, Lemaire-Ewing S, Menetrier F, Neel D, Lizard G. Activation of caspase-3-dependent and -independent pathways during 7-ketocholesterol- and 7beta-hydroxycholesterol-induced cell death: a morphological and biochemical study. J Biochem Mol Toxicol 2005;19:311–326.
   PubMed Web of Science ®Google Scholar
• Lizard G, Monier S, Cordelet C, Gesquiere L, Deckert V, Gueldry S, et al. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler Thromb Vasc Biol 1999;19:1190–1200.
   PubMed Web of Science ®Google Scholar
• Lee T, Chau L. Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 2001;280: C709–C718.
   Web of Science ®Google Scholar
• Vejux A, Lizard G, Tourneur Y, Riedinger JM, Frouin F, Kahn E. Effects of caspase inhibitors (z-VAD-fmk, z-VDVAD-fmk) on Nile Red fluorescence pattern in 7-ketocholesterol-treated cells: investigation by flow cytometry and spectral imaging microscopy. Cytometry A 2007;71:550–562.
   PubMedGoogle Scholar
• Miguet C, Monier S, Bettaieb A, Athias A, Bessede G, Laubriet A, et al. Ceramide generation occurring during 7beta-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ 2001;8:83–99.
   PubMed Web of Science ®Google Scholar
• Lordan S, O’Neill C, O’Brien NM. Effects of apigenin, lycopene and astaxanthin on 7 beta-hydroxycholesterol-induced apoptosis and Akt phosphorylation in U937 cells. Br J Nutr 2008;100:287–296.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Gamba P, Gargiulo S, Sottero B, Kadl A, Biasi F, et al. Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture. Aging Cell 2008;7:375–382.
   PubMed Web of Science ®Google Scholar
• Vejux A, Guyot S, Montange T, Riedinger JM, Kahn E, Lizard G. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J Nutr Biochem 2009;20:45–61.
   PubMed Web of Science ®Google Scholar
• Lizard G, Miguet C, Bessede G, Monier S, Gueldry S, Neel D, Gambert P. Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occuring during 7-ketocholesterol-induced apoptosis. Free Radic Biol Med 2000;28:743–753.
   PubMed Web of Science ®Google Scholar
• Lordan S, Mackrill JJ, O’Brien NM. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J Nutr Biochem 2009;20:321–336.
   PubMed Web of Science ®Google Scholar
• Ryan L, O’Callaghan YC, O’Brien NM. Comparison of the apoptotic processes induced by the oxysterols 7beta-hydroxycholesterol and cholesterol-5beta,6beta- epoxide. Cell Biol Toxicol 2004;20:313–323.
   PubMed Web of Science ®Google Scholar
• Ghelli A, Porcelli AM, Zanna C, Rugolo M. 7-Ketocholesterol and staurosporine induce opposite changes in intracellular pH, associated with distinct types of cell death in ECV304 cells. Arch Biochem Biophys 2002;402:208–217.
   Google Scholar
• Biasi F, Leonarduzzi G, Vizio B, Zanetti D, Sevanian A, Sottero B, et al. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. FASEB J 2004;18:693–695.
   PubMed Web of Science ®Google Scholar
• Larsson DA, Baird S, Nyhalah JD, Yuan XM, Li W. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. Free Radic Biol Med 2006;41:902–910.
   PubMed Web of Science ®Google Scholar
• Monier S, Samadi M, Prunet C, Denance M, Laubriet A, Athias A, et al. Impairment of the cytotoxic and oxidative activities of 7 beta-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. Biochem Biophys Res Commun 2003;303:814–824.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Biasi F, Chiarpotto E, Poli G. Trojan horse-like behavior of a biologically representative mixture of oxysterols. Mol Aspects Med 2004;25:155–167.
   PubMedGoogle Scholar
• Rutherford LD, Gieseg SP. 7-ketocholesterol is not cytotoxic to U937 cells when incorporated into acetylated low density lipoprotein. Lipids 2012;47:239–247.
   Google Scholar
• Kim YJ, Lee CS. Tyrosine kinase inhibitor AG126 reduces 7-ketocholesterol-induced cell death by suppressing mitochondria-mediated apoptotic process. Neurochem Res 2010;35:603–612.
   Google Scholar
• Malvitte L, Montange T, Joffre C, Vejux A, Maiza C, Bron A, et al. [Analogies between atherosclerosis and age-related maculopathy: expected roles of oxysterols]. J Fr Ophtalmol 2006;29:570–578.
   Google Scholar
• Ringseis R, Eder K. Dietary oxidized cholesterol decreases expression of hepatic microsomal triglyceride transfer protein in rats. J Nutr Biochem 2004;15:103–111.
   Google Scholar
• Rosenblat M, Aviram M. Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 2002;160:69–80.
   PubMed Web of Science ®Google Scholar
• Lizard G, Gueldry S, Sordet O, Monier S, Athias A, Miguet C, et al. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 1998;12:1651–1663.
   PubMed Web of Science ®Google Scholar
• O’Sullivan AJ, O’Callaghan YC, O’Brien NM. Differential effects of mixtures of cholesterol oxidation products on bovine aortic endothelial cells and human monocytic U937 cells. Int J Toxicol 2005;24:173–179.
   PubMed Web of Science ®Google Scholar
• Miguet-Alfonsi C, Prunet C, Monier S, Bessede G, Lemaire-Ewing S, Berthier A, et al. Analysis of oxidative processes and of myelin figures formation before and after the loss of mitochondrial transmembrane potential during 7beta-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals. Biochem Pharmacol 2002;64:527–541.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434–438.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649–1657.
   PubMed Web of Science ®Google Scholar
• Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339–350.
   PubMed Web of Science ®Google Scholar
• Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 2004;35:1070–1082.
   PubMed Web of Science ®Google Scholar
• Miller MH, Ferguson MA, Dillon JF. Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. Liver Int 2011;31:461–473.
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27–41.
   PubMed Web of Science ®Google Scholar
• Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Petrella A, Tamborra R, et al. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. J Pharmacol Exp Ther 2010;332:922–932.
   PubMed Web of Science ®Google Scholar
• Domenicali M, Vendemiale G, Serviddio G, Grattagliano I, Pertosa AM, Nardo B, et al. Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. Dig Liver Dis 2005;37:689–697.
   PubMedGoogle Scholar
• Rodriguez JL, Sandoval J, Serviddio G, Sastre J, Morante M, Perrelli MG, et al. Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration. Biochem J 2006;398:431–437.
   Google Scholar
• Petta S, Muratore C, Craxi A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis 2009;41:615–625.
   PubMedGoogle Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”?Gastroenterology 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• Ferre N, Martinez-Clemente M, Lopez-Parra M, Gonzalez-Periz A, Horrillo R, Planaguma A, et al. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am J Physiol Gastrointest Liver Physiol 2009; 296:G553–G562.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209–218.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247–2250.
   PubMed Web of Science ®Google Scholar
• Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006;290:G1083–G1088.
   PubMed Web of Science ®Google Scholar
• Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:370–379.
   PubMed Web of Science ®Google Scholar
• Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, et al. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 2001; 33:713–721.
   Google Scholar
• Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, et al. Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J Hepatol 2007;46:230–238.
   PubMed Web of Science ®Google Scholar
• Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001;250:91–104.
   PubMed Web of Science ®Google Scholar
• Masumoto T, Ohkubo K, Yamamoto K, Ninomiya T, Abe M, Akbar SM, et al. Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis. Hepatogastroenterology 1998;45:1630–1634.
   Google Scholar
• Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002;7:d793–d807.
   PubMed Web of Science ®Google Scholar
• Ikegami T, Hyogo H, Honda A, Miyazaki T, Tokushige K, Hashimoto E, et al. Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease. J Gastroenterol 2012;47:1257–1266.
   Google Scholar
• Reschly EJ, Ai N, Welsh WJ, Ekins S, Hagey LR, Krasowski MD. Ligand specificity and evolution of liver X receptors. J Steroid Biochem Mol Biol 2008;110:83–94.
   PubMed Web of Science ®Google Scholar
• DeBose-Boyd RA, Ou J, Goldstein JL, Brown MS. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc Natl Acad Sci U S A 2001;98:1477–1482.
   PubMed Web of Science ®Google Scholar
• Nakamuta M, Fujino T, Yada R, Yada M, Yasutake K, Yoshimoto T, et al. Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med 2009;23:603–608.
   Google Scholar
• Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, et al. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 2008;38:1122–1129.
   PubMed Web of Science ®Google Scholar
• Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, et al. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 2009;58:203–208.
   PubMed Web of Science ®Google Scholar
• Van Rooyen DM, Larter CZ, Haigh WG, Yeh MM, Ioannou G, Kuver R, et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011;141:1393–403, 1403.
   PubMed Web of Science ®Google Scholar
• Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 2008;65:2493–2506.
   PubMed Web of Science ®Google Scholar
• Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Capitanio N, Tamborra R, et al. Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. Free Radic Biol Med 2011;51:2234–2242.
   PubMed Web of Science ®Google Scholar
• Tamasawa N, Tamasawa A, Takebe K, Hayakari M. The effect of dietary 7-ketocholesterol, inhibitor of sterol synthesis, on hepatic microsomal cholesterol 7 alpha-hydroxylase activity in rat. Biochim Biophys Acta 1994;1214:20–26.
   Google Scholar
• Breuer O, Sudjana-Sugiaman E, Eggertsen G, Chiang JY, Bjorkhem I. Cholesterol 7 alpha-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. Eur J Biochem 1993;215:705–710.
   Google Scholar
• Lyons MA, Brown AJ. 7-Ketocholesterol. Int J Biochem Cell Biol 1999;31:369–375.
   PubMed Web of Science ®Google Scholar
• Cantwell H, Devery R. The response of the antioxidant defense system in rat hepatocytes challenged with oxysterols is modified by Covi-ox. Cell Biol Toxicol 1998;14:401–409.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang T, Huang K. Cholestane-3beta,5alpha,6beta-triol-induced reactive oxygen species production promotes mitochondrial dysfunction in isolated mice liver mitochondria. Chem Biol Interact 2009;179:81–87.
   PubMed Web of Science ®Google Scholar
• Xu L, Bai Q, Rodriguez-Agudo D, Hylemon PB, Heuman DM, Pandak WM, Ren S. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate. Lipids 2010;45:821–832.
   PubMed Web of Science ®Google Scholar
• Ren S, Li X, Rodriguez-Agudo D, Gil G, Hylemon P, Pandak WM. Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes. Biochem Biophys Res Commun 2007;360:802–808.
   Google Scholar
• Bai Q, Zhang X, Xu L, Kakiyama G, Heuman D, Sanyal A, et al. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. Metabolism 2012;61:836–845.
   PubMed Web of Science ®Google Scholar
• Hessvik NP, Bakke SS, Smith R, Ravna AW, Sylte I, Rustan AC, et al. The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism. J Steroid Biochem Mol Biol 2012;128:154–164.
   Google Scholar
• Walenbergh S, Bieghs, V, Hendriks, T. 27-Hydroxycholesterol: a potential treatment for non alcholic steatohepatitis in mice. Hepatology 2012;56:862A.
   Google Scholar
• Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, et al. The nuclear receptor LXR is a glucose sensor. Nature 2007;445:219–223.
   PubMed Web of Science ®Google Scholar
• Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009;325:100–104.
   PubMed Web of Science ®Google Scholar
• Wouters K, van Bilsen M, van Gorp PJ, Bieghs V, Lutjohann D, Kerksiek A, et al. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS Lett 2010;584:1001–1005.
   PubMed Web of Science ®Google Scholar
• Liu Y, Han X, Bian Z, Peng Y, You Z, Wang Q, et al. Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease. Dig Dis Sci 2012;57:390–398.
   PubMed Web of Science ®Google Scholar
• Beaven SW, Wroblewski K, Wang J, Hong C, Bensinger S, Tsukamoto H, Tontonoz P. Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology 2011;140: 1052–1062.
   PubMed Web of Science ®Google Scholar
• Liu Y, Qiu DK, Ma X. Liver X receptors bridge hepatic lipid metabolism and inflammation. J Dig Dis 2012;13:69–74.
   Google Scholar
• Lima-Cabello E, Garcia-Mediavilla MV, Miquilena- Colina ME, Vargas-Castrillon J, Lozano-Rodriguez T, Fernandez-Bermejo M, et al. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin Sci (Lond) 2011;120:239–250.
   PubMed Web of Science ®Google Scholar
• Inaba T, Matsuda M, Shimamura M, Takei N, Terasaka N, Ando Y, et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem 2003;278:21344–21351.
   PubMed Web of Science ®Google Scholar
• Jakel H, Nowak M, Moitrot E, Dehondt H, Hum DW, Pennacchio LA, et al. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J Biol Chem 2004;279:45462–45469.
   PubMedGoogle Scholar
• Caballero F, Fernandez A, De Lacy AM, Fernandez-Checa JC, Caballeria J, Garcia-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol 2009;50:789–796.
   PubMed Web of Science ®Google Scholar
• Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 2012;15: 665–674.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007;45:1366–1374.
   PubMed Web of Science ®Google Scholar
• Valastyan S, Thakur V, Johnson A, Kumar K, Manor D. Novel transcriptional activities of vitamin E: inhibition of cholesterol biosynthesis. Biochemistry 2008;47: 744–752.
   Google Scholar
• Landrier JF, Gouranton E, Reboul E, Cardinault N, El YC, Malezet-Desmoulins C, et al. Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells. J Nutr Biochem 2010; 21:1207–1213.
   PubMed Web of Science ®Google Scholar
• Iuliano L, Lizard G. Oxysterols and related sterols in chemistry, biology and medicine: a dynamic European field of investigation. Biochimie 2013;95:445–447.
   Google Scholar